Pluristem Therapeutics Inc (PSTI)

[HappyBee]

Hi Melon and FDA,

Melon, I think the example of the NSAIDs makes a lot of sense in connection with Pluristem and its place within the placental cell therapy market. I am not too worried either about any potential competitors. Pluristem's patent portfolio is a very valuable asset and should not be underestimated.

FDA, thank you for posting the links, especially the one to the Abstract on the Biorxiv website. The new results appear to be very good news.

Best wishes,

HappyBee